National Comprehensive Cancer Network

Policy Updates

Policy Summit: Redefining Quality Measurement in Oncology - Article Now Available!

Policy Summit: Developments in Biosimiliars and Molecular Testing - Article Now Available!

Patient Advocacy Summit: Value Tools for Patients in Cancer Care - Article Now Available!

Patient Advocacy Summit: Value in Cancer Care - Patient Perspectives on Access to Cancer Care: Panel Video 1

Patient Advocacy Summit: Value in Cancer Care - Defining Value for Patients with Cancer: Panel Video 2

Patient Advocacy Summit: Value in Cancer Care - Patient Perspectives on the Cost of Cancer Care: Panel Video 3

Patient Advocacy Summit: Value in Cancer Care – Patient Perspectives: In-depth Summary

Policy Summit: Emerging Issues and Opportunities in Health Information Technology – Article Now Available!

Policy Summit: Emerging Issues in Tissue Allocation: In-depth Summary

Policy Summit: Emerging Issues in Tissue Allocation: White Paper

NCCN Online CME/CE

Interactive CME

Supporter Opportunities

Educational Events & Programs

Date > Thursday, 18 October, 2018 > Enroll Now!

Location > Sofitel Munich Bayerpost Munich, Germany

OVERVIEW

Pharmaceutical and biotechnology professionals are given the rare opportunity to view the global oncology space, its future and its current operational issues from the provider, payer, and patient advocate perspective. Participants will improve their working knowledge of key global business, policy, informational, and operational issues in oncology and will gather valuable insights material to developing effective strategies for navigating the various constituencies in consideration of worldwide cancer care issues. Through this interactive program, pharmaceutical and biotech professionals will learn from key stakeholders what they view to be the most pressing issues in the global oncology environment and how to apply this knowledge to create mutually successful working relationships.

Professionals from marketing, sales, advocacy, medical affairs, clinical research, international programs, policy and government affairs, and other business areas will better be able to serve their customers with improved knowledge of real-world oncology issues after completion of this program.

Please check back often for additional updates regarding this program. If you have any questions, please contact Caitlin Donnelly, Global Business Development Specialist.

A summary of the inaugural NCCN the Global Academy, held October 6, 2017 is available here.

CURRICULUM*

12:45 – 1:45 PM	Lunch
1:45 – 1:50 PM	Welcome Caitlin Donnelly Senior Global Business Development Specialist National Comprehensive Cancer Network
1:50 – 2:00 PM	Introduction to Global Initiatives C. Lyn Fitzgerald, MJ Senior Vice President, U.S. & Global Development National Comprehensive Cancer Network
2:05 – 3:25 PM	Module I: Regional Adaptations - Meet NCCN Guidelines Panel and Collaborative International Experts Moderator: Wui-Jin Koh, MD Senior Vice President/Chief Medical Officer National Comprehensive Cancer Network Meet NCCN’s New CMO! Panelists: Al B. Benson III, MD, FACP, FASCO / Chair Professor of Medicine Associate Director for Cooperative Groups Chair, NCCN Guidelines for Colon/Rectal/Anal and Hepatobiliary Cancers Panels Member, NCCN Guidelines for Neuroendocrine and Adrenal Tumors and Pancreatic Adenocarcinoma Board Member, National Comprehensive Cancer Network Board Member, NCCN Foundation Robert H. Lurie Comprehensive Cancer Center of Northwestern University William J. Gradishar, MD / Chair Betsy Bramsen Professor of Breast Oncology, Chief, Division of Hematology/Oncology Director, Maggie Daley Center for Women`s Cancer Care, Director, Breast Medical Oncology Chair, NCCN Guidelines for Breast Cancer Panel Member, NCCN Guidelines for Breast Cancer Risk Reduction Panel Robert H. Lurie Comprehensive Cancer Center of Northwestern University Abdul Rahman Jazieh, MD, MPH Chairman, Department of Oncology, King Abdulaziz Medical City in Riyadh, Saudi Arabia NCCN Guideline for Non-Small Cell Lung Cancer Collaborative International Expert Director of the Coordinating Center, MENA Gilian Wharfe, MD Overall Clinical Chair 2018 NCCN Harmonized Guidelines™ for the Caribbean: Colon Cancer Collaborative International Expert Haematologist/Oncologist Head if the Department of Pathology The University of the West Indies, MONA Jamaica
3:25 – 3:40 PM	Break
3:45 – 5:05 PM	Module II: Harmonizing Cancer Care for Patients with Resource Constraints Moderator C. Lyn Fitzgerald, MJ Senior Vice President, U.S. & Global Development National Comprehensive Cancer Network Panelists: Baffour Awuah, MD, FCRadOnc (SA), MBA Ministry of Health, Accra Special Advisor to Minister Consultant Radiation/ Clinical Oncologist Komfo Anokye Teaching Hospital, Kumasi, Ghana Ambassador Sally G. Cowal, MA Board Member of the Union of International Cancer Control (UICC) Senior Vice President, Global Cancer Control American Cancer Society Patricia Doykos, PhD Director Bristol-Myers Squibb Foundation Wui-Jin Koh, MD Senior Vice President/Chief Medical Officer National Comprehensive Cancer Network
5:05 – 5:10 PM	Closing Remarks Jorge Bacigalupo Global Business Development Program Manager National Comprehensive Cancer Network

*Curriculum subject to change.

LOCATION

Sofitel Munich Bayerpost
Bayerstrasse 12, Munich, 80335
Schwabing 1-3

Customize your own NCCN Academy curriculum.

NCCN offers the unique opportunity to customize an NCCN Academy curriculum that best aligns with your organization's particular needs and interests.

Approximately 97 percent of recent NCCN Academy attendees say they would attend an NCCN Academy program again or recommend that colleagues attend.